Global Defibrillator Market Outlook, 2031

The global defibrillator market has emerged as a critical segment within the cardiac care medical device industry, providing life-saving devices that deliver therapeutic electrical shocks to restore normal heart rhythm in patients experiencing life-threatening arrhythmias such as ventricular fibrillation and pulseless ventricular tachycardia . Defibrillators are available in various forms, including implantable cardioverter defibrillators (ICDs) for long-term cardiac monitoring and therapy, external defibrillators for emergency and public access use, and wearable defibrillators for temporary protection . These devices are essential for treating sudden cardiac arrest, improving survival rates, and managing chronic cardiac conditions across hospital, prehospital, and homecare settings. The market is experiencing significant transformation driven by the rising prevalence of cardiovascular diseases globally, an aging population, and technological innovations in device design and functionality.

According to the research report " Global Defibrillator Market Outlook, 2031," published by Bonafide Research, the Global Defibrillator market was valued at USD 11 Billion in 2025. The adoption of AI-enabled rhythm detection, cloud-based remote monitoring, and miniaturized extravascular ICDs is reshaping the competitive landscape, while regulatory frameworks such as the EU Medical Device Regulation and FDA requirements for cybersecurity compliance are influencing product development and market access . Public-access defibrillation programs and government initiatives to improve emergency response infrastructure are expanding the addressable market, particularly in developed regions .

Drivers Rising prevalence of cardiovascular diseases and sudden cardiac arrest: The increasing global burden of cardiovascular diseases is a primary driver for the defibrillator market. According to the American Heart Association, over 61% of adults in the U.S. are projected to have cardiovascular disease by 2050, with hypertension alone expected to affect 184 million people.

Technological advancements in ICDs and AEDs: Innovations in device design are significantly boosting market growth. FDA approval of Medtronic's Aurora EV-ICD in 2023 shifted the market toward extravascular implantation, avoiding venous complications while delivering antitachycardia.

Challenges Frequent product recalls and regulatory scrutiny: Defibrillators, including AEDs and ICDs, have faced frequent product recalls due to manufacturing defects, software errors, battery issues, or electrode connectivity failures that can delay or prevent shock delivery.



Stringent multi-region regulatory frameworks: The EU Medical Device Regulation (MDR 2017/745) obliges recertification of legacy products, with roughly one-third of devices slated for exit owing to cost and timeline burdens . Across the Atlantic, the U.S. FDA requires software bills of materials and vulnerability reporting for cyber devices, adding documentation layers that elongate clearance cycles .

Trends Shift toward smart, connected defibrillators: The defibrillator market is moving from traditional devices to smart, connected solutions that leverage AI-driven rhythm detection, predictive analytics, and cloud-based remote monitoring . Integration with hospitals and EMS systems, improved interoperability across care settings, and enhanced chronic cardiac patient management are key trends enabling faster emergency response and higher survival rates .

Expansion of public-access defibrillation programs: Government initiatives and mandates aimed at boosting the availability of automated external defibrillators in public spaces, workplaces, and schools are providing significant support for market expansion .

The market is segmented by product into implantable cardioverter defibrillators (ICDs) and external defibrillators, with ICDs currently holding the largest market share due to their life-saving features and long-term implantation. Implantable cardioverter defibrillators reaffirming physician familiarity and robust clinical evidence . ICDs are surgically implanted devices that monitor heart rhythms continuously and automatically deliver shocks or pacing therapy when natural corrective mechanisms fail, such as for ventricular tachycardia or ventricular fibrillation . Adoption benefits from Medtronic's extravascular approach, which eliminates venous leads and extends battery life, fostering replacement demand . The ICD segment includes cardiac resynchronization therapy defibrillators (CRT-D), transvenous ICDs (single-chamber, dual-chamber), and subcutaneous ICDs. CRT-D devices integrate ultrasound-based pacing and promise lower complication loads, supporting steady growth among heart-failure cohorts . Subcutaneous systems, now feasible even in toddlers, widen addressable populations . This segment includes automated external defibrillators (AEDs) for public access, manual defibrillators for healthcare professionals, and wearable cardioverter defibrillators for temporary protection of patients at risk of sudden cardiac arrest .

The market is segmented by end user into hospitals and clinics, prehospital settings, public access settings, home care settings, and alternate care facilities, with hospitals currently holding the largest market share. Hospitals and clinics represent the dominant end-user segment, holding the largest share due to high patient volumes, especially those with cardiac conditions, and the availability of advanced medical infrastructure . These settings require both external and implantable defibrillators for emergency and critical care, with supportive reimbursement policies and the growing prevalence of heart disease driving demand . The hospital segment driven by the large pool of patients visiting hospitals for diagnosis and treatment . Prehospital settings, including emergency medical services and ambulance services, represent a significant segment requiring portable defibrillators for rapid response to out-of-hospital cardiac arrests. Public access settings are the fastest-growing segment, driven by government mandates and initiatives to install AEDs in public spaces, workplaces, schools, and transportation hubs .

North America leads the global defibrillator market, driven by integrated emergency systems, reimbursement clarity, and early adoption of technological innovations. North America contributed 43.85% of market share in 2025, supported by integrated emergency systems and reimbursement clarity . King County's 5,000-plus registered AEDs linked to dispatch exemplify best-practice public-access integration . The FDA's prompt clearance of innovations like the Aurora EV-ICD and Jewel Patch cultivates early adoption, reinforcing regional leadership . Drone pilots in North Carolina cut response times to 4 minutes, hinting at further survival gains once scaled . The U.S. market benefits from favorable reimbursement policies, high healthcare expenditure, and the presence of major medical device manufacturers such as Medtronic, Abbott, Boston Scientific, and Stryker . Canada follows similar trends with a mature healthcare system and growing adoption of public-access defibrillation programs. The region's strong regulatory frameworks, well-established emergency response infrastructure, and high awareness of sudden cardiac arrest ensure its continued dominance through 2031.

In 2025 — Element Science's Jewel Patch wearable defibrillator won FDA clearance after demonstrating high compliance and low inappropriate-shock rates, marking a milestone in wearable cardiac protection .

In 2025 — The U.S. FDA continued to require software bills of materials and vulnerability reporting for cyber devices, adding documentation layers that elongate clearance cycles .

In 2024 — Stryker announced the launch of the LIFEPAK 35 monitor/defibrillator, which offers advanced technology built on an intuitive, modern platform to help advance patient care .

In 2024 — Nihon Kohden Corporation opened Nihon Kohden Vietnam, a wholly owned subsidiary, to facilitate regulatory registration and drive sales of medical devices in Vietnam .


Considered in this report
• Historic Year: 2020
• Base Year: 2025
• Estimated Year: 2026
• Forecast Year: 2031

Aspects covered in this report
• Global Defibrillator Market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By Product
• Implantable Cardioverter Defibrillators
• Cardiac Resynchronization Therapy (CRT) Defibrillator
• Transvenous ICD
• Subcutaneous ICD
• External Defibrillators
• Manual Defibrillators
• Automated Defibrillators
• Wearable Defibrillators

By End User
• Alternate Care Facilities
• Homecare
• Hospitals & Clinics
• Prehospital
• Public Access